Prostaglandins and nitric oxide as molecular targets for anti-inflammatory therapy
- 3 August 2000
- journal article
- review article
- Published by Elsevier in Fitoterapia
- Vol. 71, S48-S57
- https://doi.org/10.1016/s0367-326x(00)00181-7
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Theaflavin-3,3′-digallate from black tea blocks the nitric oxide synthase by down-regulating the activation of NF-κB in macrophagesEuropean Journal of Pharmacology, 1999
- Ursolic Acid fromPlantagomajor, a Selective Inhibitor of Cyclooxygenase-2 Catalyzed Prostaglandin BiosynthesisJournal of Natural Products, 1998
- Yomogin, an inhibitor of nitric oxide production in LPS-activated macrophagesArchives of Pharmacal Research, 1998
- Inducible nitric oxide synthase: what difference does it make?Journal of Clinical Investigation, 1997
- Inhibition of the Expression of Inducible Cyclooxygenase and Proinflammatory Cytokines by Sesquiterpene Lactones in Macrophages Correlates with the Inhibition of MAP KinasesBiochemical and Biophysical Research Communications, 1996
- Interaction between nitric oxide and cyclooxygenase pathwaysProstaglandins, Leukotrienes & Essential Fatty Acids, 1996
- Mechanism by which garlic (Allium sativum) inhibits cyclooxygenase activity. Effect of raw versus boiled garlic extract on the synthesis of prostanoidsProstaglandins, Leukotrienes & Essential Fatty Acids, 1995
- Non-Steroidal Anti-Inflammatory DrugsDrugs, 1984
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971